Is A Short Squeeze Ahead for Ariad Pharmaceuticals, Inc. (ARIA)? - Tale of the Tape
January 13 2014 - 7:29AM
Zacks
Many investors appear to be quite bearish
Ariad Pharmaceuticals, Inc.
(ARIA) especially if you
look at the percentage of the float that is sold short for this
stock. Currently, 24.6% of the float is
sold short, suggesting an extreme level of bearishness for
ARIA.
However, it is worth noting that earnings estimates have actually
been moving higher for the company, despite the pessimism. Thanks
to these rising estimates, we actually have a Zacks
Rank #2(Buy) on
ARIA, so we clearly don’t believe in the
negativity surrounding this firm, and are instead looking for
shares of ARIA to move higher in the weeks
ahead.
ARIAD PHARMA (ARIA): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Ariad (NASDAQ:ARIA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Ariad (NASDAQ:ARIA)
Historical Stock Chart
From Sep 2023 to Sep 2024